Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4

Infection and Immunity

Volumn 72, Issue 10, 2004, Pages 5605-5612

  Burns Jr , James M ^a   Flaherty, Patrick R ^b   Nanavati, Payai ^a   Weidanz, William P ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN SPECIFIC ANTIBODY; APICAL MEMBRANE ANTIGEN 1; CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2C ANTIBODY; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM CHABAUDI MEROZOITE SURFACE PROTEIN 1-42; RECOMBINANT PLASMODIUM CHABAUDI APICAL MEMBRANE ANTIGEN 1; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY MEDIATED IMMUNITY; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; GAMMA DELTA T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; KNOCKOUT MOUSE; MALARIA; MOUSE; NONHUMAN; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; MALARIA; MALARIA VACCINES; MALE; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED C57BL; PLASMODIUM CHABAUDI; PROTOZOAN PROTEINS; TIME FACTORS; VACCINATION;

EID: 4644359502     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.10.5605-5612.2004     Document Type: Article

References (55)

1. Ahlborg, N., I. T. Ling, W. Howard, A. A. Holder, and E. M. Riley. 2002. Protective immune responses to the 42-kilodalton (KDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not the adjacent 33-kDa region. Infect. Immun. 70:820-825.
2. Anders, R. A., P. E. Crewther, S. Edwards, M. Margetts, M. L. S. M. Matthew, B. Pollock, and D. Pye. 1997. Immunization with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16:240-247.
3. Batchelder, J. M., J. M. Burns, Jr., F. K. Cigel, H. Lieberg, D. D. Manning, B. J. Pepper, D. M. Yanez, H. van der Heyde, and W. P. Weidanz. 2003. Plasmodium chabaudi: IFN-γ but not IL-2 is essential for the expression of cell-mediated immunity against blood-stage parasites in mice. Exp. Parasitol. 105:159-166.
4. Bouharoun-Tayoun, H., and P. Druilhe. 1992. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 60:1473-1481.
5. Bouharoun-Tayoun, H., C. Oeuvray, F. Lunel, and P. Druilhe. 1995. Mechanism underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 182:409-418.
6. Breman, J. G. 1999. The ears of the hippopotamus; manifestations, determinants and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 648:1-11.
7. Burns, J. M., Jr., P. R. Flaherty, M. M. Romero, and W. P. Weidanz. 2003. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1. Vaccine 21:1843-1852.
8. Carlton, J. M., S. V. Angiuoli, B. B. Suh, T. W. Kooij, M. Pertea, J. C. Silva, M. D. Ermolaeva, J. E. Allen, J. D. Selengut, H. L. Koo, J. D. Peterson, M. Pop, D. S. Kosack, M. F. Shumway, S. L. Bidwell, S. J. Shallom, S. E. van Aken, S. B. Riedmuller, T. V. Feldblyum, J. K. Cho, J. Quackenbush, M. Sedegah, A. Shoaibi, L. M. Cummings, L. Florens, J. R. Yates, J. D. Raine, R. E. Sinden, M. A. Harris, D. A. Cunningham, P. R. Preiser, L. W. Bergman, A. B. Vaidya, L. H. van Lin, C. J. Janse, A. P. Waters, H. O. Smith, O. R. White, S. L. Salzberg, J. C. Venter, C. M. Fraser, S. L. Hoffman, M. J. Gardner, and D. J. Carucci. 2002. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 419:512-519.
9. Chen, J., M. Trounstine, F. W. Alt, F. Young, C. Kurahara, J. F. Loring, and D. Huszar. 1993. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5:647-656.
10. Clark, I. A., and W. B. Cowden. 2003. The pathophysiology of falciparum malaria. Pharmacol. Ther. 99:221-260.
11. Crewther, P. E., M. L. S. M. Matthew, R. H. Flegg, and R. Anders. 1996. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 64:3310-3317.
12. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted Interferon-γ genes. Science 259:1739-1742.
13. Daly, T. M., and C. A. Long. 1995. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 155:236-243.
14. Daly, T. M., and C. A. Long. 1996. Influence of adjuvant on protection induced by a recombinant fusion protein against malaria infection. Infect. Immun. 64:2602-2608.
15. Deleersnijder, W., D. Hendrix, N. Bendahman, J. Hanegreefs, L. Brijs, C. Hamers-Casterman, and R. Hamers. 1990. Molecular cloning and sequence analysis of the gene encoding the major merozoite surface antigen of Plasmodium chabaudi chabaudi IP-PC1. Mol. Biochem. Parasitol. 43:231-244.
16. Egan, A., M. Waterfall, M. Pinder, A. Holder, and E. Riley. 1997. Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds. Infect. Immun. 65:3024-3031.
17. 19, the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect. Immun. 63:456-466.
18. Gardner, M. J., N. Hall, E. Fung, O. White, M. Berriman, R. W. Hyman, J. M. Carlton, A. Pain, K. E. Nelson, S. Bowman, I. T. Paulsen, K. James, J. A. Eisen, K. Rutherford, S. L. Salzberg, A. Craig, S. Kyes, M. S. Chan, V. Nene, S. J. Shallom, B. Suh, J. Peterson, S. Angiuoli, M. Pertea, J. Allen, J. Selengut, D. Haft, M. W. Mather, A. B. Vaidya, D. M. Martin, A. H. Fairlamb, M. J. Fraunholz, D. S. Roos, S. A. Ralph, G. I. McFadden, L. M. Cummings, G. M. Subramanian, C. Mungall, J. C. Venter, D. J. Carucci, S. L. Hoffman, C. Newbold, R. W. Davis, C. M. Fraser, and B. Barrell. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498-511.
19. Greenwood, B., and P. Alonso. 2002. Malaria vaccine trials. Chem. Immunol. 80:366-395.
20. Groux, H., and J. Gysin. 1990. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclass. Res. Immunol. 141:529-542.
21. Grun, J. L., and W. P. Weidanz. 1981. Immunity to Plasmodium chabaudi adami in the B-cell deficient mouse. Nature 290:143-145.
22. 19) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. J. Immunol. 159:3400-3411.
23. Hirunpetcharat, C., P. Vukovic, X. Q. Liu, D. C. Kaslow, L. H. Miller, and M. F. Good. 1999. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1. J. Immunol. 162:7309-7314.
24. Hodder, A. N., P. E. Crewther, and R. A. Anders. 2001. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 69:3286-3294.
25. Hohara, S., P. Mombaerts, J. Lafaille, J. Iacomini, A. Nelson, A. R. Clark, M. L. Hooper, A. Farr, and S. Tonegawa. 1993. T cell receptor mutant mice: independent generation of αβ cells and programmed rearrangement of γδ TCR genes. Cell 72:337-348.
26. Holder, A. A. 1996. Preventing merozoite invasion of erythrocytes, p. 77-104. In S. L. Hoffman (ed.), Malaria vaccine development: a multi-immune response approach. ASM Press, Washington, D.C.
27. Hollingdale, M. R., and U. Krzych. 2002. Immune responses to liver-stage parasites: implications for vaccine development. Chem. Immunol. 80:97-124.
28. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707-710.
29. Kumar, S., J. E. Epstein, and T. L. Richie. 2002. Vaccine against asexual stage malaria parasites. Chem. Immunol. 80:262-286.
30. Kumar, S, A. Yadava, D. B. Keister, J. H. Tian, M. Ohl, K. A. Perdue-Greenfield, L. H. Miller, and D. C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325-332.
31. Langhorne, J., S. Gillard, B. Simon, S. Slade, and K. Eichman. 1989. Frequencies of CD4+ T cells reactive with Plasmodium chabaudi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during infection. Int. Immunol. 1:416-424.
32. Marshall, V. M., M. G. Peterson, A. M. Lew, and D. J. Kemp. 1989. Structure of the apical membrane antigen I (AMA-1) of Plasmodium chabaudi. Mol. Biochem. Parasitol. 37:281-284.
33. Martin, R. M., J. L. Brady, and A. M. Lew. 1998. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 212:187-192.
34. McKean, P. G., K. O'Dea, and K. N. Brown. 1993. Nucleotide sequence analysis and epitope mapping of the merozoite surface protein 1 from Plasmodium chabaudi chabaudi AS. Mol. Biochem. Parasitol. 62:199-210.
35. Mohan, K., and M. M. Stevenson. 1998. Acquired immunity to asexual blood stages, p. 467-493. In I. W. Sherman (ed.), Malaria: parasite biology, pathogenesis, and protection. ASM Press, Washington, D.C.
36. Perlmann, P., and M. Troye-Blomberg. 2002. Malaria and the immune system in humans. Chem. Immunol. 80:229-242.
37. Richie, T. L., and A. Saul. 2002. Progress and challenges for malaria vaccines. Nature 415:694-701.
38. Rotman, H. L., T. M. Daly, R. Clynes, and C. A. Long. 1998. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model. J. Immunol. 161:1908-1912.
39. Rotman, H. L., T. M. Daly, and C. A. Long. 1999. Plasmodium: immunization with the carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge. Exp. Parasitol. 91:78-85.
40. Stevenson, M. M., and E. Riley. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4:169-180.
41. Stevenson, M. M., and M. F. Tam. 1993. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi (AS) infection in resistant and susceptible mice. Clin. Exp. Immunol. 92:77-83.
42. Su, Z., and M. M. Stevenson. 2000. Central role of endogenous gamma Interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect. Immun. 68:4399-4406.
43. Su, Z., and M. M. Stevenson. 2002. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168:1348-1355.
44. Su, Z., M. Tam, D. Jankovic, and M. M. Stevenson. 2003. Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice. Infect. Immun. 71:5178-5187.
45. Udhayakumar, V., D. Anyona, S. Kariuki, Y. P. Shi, P. B. Bloland, O. H. Branch, W. Weiss, B. L. Nahlen, D. C. Kaslow, and A. A. Lal. 1995. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J. Immunol. 154:6022-6030.
46. van der Heyde, H. C., W.-L. Chang, and W. P. Weidanz. 1997. Specific immunity to malaria and the pathogenesis of disease, p. 195-226. In S. H. E. Kaufmann (ed.), Host response to intracellular pathogens. R. G. Landes Company Biomedical Publishers, Austin, Tex.
47. van der Heyde, H. C., M. M. Elloso, W.-L. Chang, M. Kaplan, D. D. Manning, and W. P. Weidanz. 1995. γδ T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria. J. Immunol. 154:3985-3990.
48. HD mouse. J. Immunol. 152:4557-4562.
49. van der Heyde, H. C., B. Pepper, J. Batchelder, F. Cigel, and W. P. Weidanz. 1997. The time course of selected malarial infections in cytokine-deficient mice. Exp. Parasitol. 85:206-213.
50. von der Weid, T., N. Honarvar, and J. Langhorne. 1996. Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J. Immunol. 156:2510-2516.
51. Vukovic, P., P. M. Hogarth, N. Barnes, D. C. Kaslow, and M. G. Good. 2000. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-γRI receptors. Infect. Immun. 68:3019-3022.
52. Weidanz, W. P., J. R. Kemp, J. M. Batchelder, F. K. Cigel, M. Sandor, and H. C. van der Heyde. 1999. Plasticity of immune response suppressing parasitemia during acute Plasmodium chabaudi malaria. J. Immunol. 162:7383-7388.
53. White, W. I., C. B. Evans, and D. W. Taylor. 1991. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii. Infect. Immun. 59:3547-3554.
54. Wipasa, J., C. Hirunpetcharat, Y. Mahakunkijcharoen, H. Xu, S. Elliott, and M. F. Good. 2002. Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria. J. Immunol. 169:944-951.
55. Xu, H., A. N. Hodder, H. Van, P. E. Crewther, R. A. Anders, and M. J. Good. 2000. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization. J. Immunol. 165:389-396.